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Abstract 
Background: Acute kidney injury (AKI) is a severe disease with high morbidity and mortality. Methods that promote 
repair of the injured kidney have been extensively investigated. Cell‑based therapy with mesenchymal stem cells or 
renal progenitor cells (RPCs) resident in the kidney has appeared to be an effective strategy for the treatment of AKI. 
Embryonic stem cells or induced pluripotent stem cells (iPSCs) are also utilized for AKI recovery. However, the thera‑
peutic effect of iPSC‑derived RPCs for AKI has yet to be determined.
Methods: In this study, we induced iPSCs differentiation into RPCs using a nephrogenic cocktail of factors combined 
with the renal epithelial cell growth medium. We then established the rat ischemia–reperfusion injury (IR) model and 
transplanted the iPSC‑derived RPCs into the injured rats in combination with the hydrogel. Next, we examined the 
renal function‑related markers and renal histology to assess the therapeutic effect of the injected cells. Moreover, we 
investigated the mechanism by which iPSC‑derived RPCs affect AKI caused by IR.
Results: We showed that the differentiation efficiency of iPSCs to RPCs increased when cultured with renal epithe‑
lial cell growth medium after stimulation with a nephrogenic cocktail of factors. The transplantation of iPSC‑derived 
RPCs decreased the levels of biomarkers indicative of renal injury and attenuated the necrosis and apoptosis of renal 
tissues, but resulted in the up‑regulation of renal tubules formation, cell proliferation, and the expression of pro‑renal 
factors.
Conclusion: Our results revealed that iPSC‑derived RPCs can protect AKI rat from renal function impairment and 
severe tubular injury by up‑regulating the renal tubules formation, promoting cell proliferation, reducing apoptosis, 
and regulating the microenvironment in the injured kidney.
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Background
Acute kidney injury (AKI) is characterized by acute tubu-
lar injury and a rapid decline in renal function [1]. Renal 
ischemia is one of the most common causes of AKI. 
AKI has recently received increasing attention due to 
the high mortality and morbidity rates of the syndrome 
[2]. Although pharmacological therapy, modern dialy-
sis techniques, and intermittent or continuous renal 
replacement therapies exist, the therapeutic approaches 
for AKI remain very limited. Thus, the establishment of 
novel therapeutic strategies for ischemic AKI is urgently 
needed.
In response to acute injury, the adult kidney shows 
some level of regeneration characterized by the prolif-
eration of the surviving cells and the replacement of the 
necrotic tubular cells with functional tubular epithelium 
[3]. The process is hypothesized to involve epithelial 
cell dedifferentiation, interstitial cell transdifferentia-
tion and/or activation of quiescent stem cells. Over the 
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last few years, renal progenitor cells (RPCs) have been 
isolated from the kidney [4–7]. Several studies have indi-
cated that RPCs appear to play important roles in kidney 
repair under various pathological conditions [4, 8–10]. 
However, progenitor cells in the adult kidney are rare, 
which limits the application of these cells. Therefore, we 
resorted to other types of stem cells.
Stem cells, including embryonic stem cells (ESCs) and 
adult stem cells, have the potential of self-renewal and 
differentiation into multiple cell types and therefore 
hold great promise in regenerative medicine [11–13]. It 
was recently reported that stem cells exhibit therapeutic 
potential for AKI [14–17]. Several studies have demon-
strated that the exposure of ESCs to factors required for 
renal specification, such as retinoic acid, activin A and 
bone morphogenic proteins (BMPs), does induce their 
differentiation into renal lineage cells in  vitro [18–20]. 
Vigneau et  al. [10] showed that the transplantation of 
mouse ESCs-derived RPCs can result in the stable inte-
gration into proximal tubules with normal morphol-
ogy and normal polarization injection into developing 
live newborn mouse kidneys, suggesting the potential of 
ESCs for application in regenerative therapies. However, 
the use of ESCs for human therapy raises several safety 
and ethical concerns.
Induced pluripotent stem cells (iPSCs) are a type of 
newly defined stem cell with properties similar to those 
of ESCs in terms of self-renewal and differentiation. 
These cells were first generated by Yamanaka and col-
leagues [21]. Since their discovery, iPSCs have shown 
their advantages in regenerative medicine. iPSCs have 
also been reported to be effective for AKI. Lee and col-
leagues [16] showed that the injection of iPSCs into the 
kidney improves renal function and attenuates renal 
tubular injury in AKI caused by ischemia–reperfusion 
injury (IR) and eventually improves the survival rate of 
rats with AKI. Although iPSCs are an alternative poten-
tial cell source for stem cell therapy to protect against 
AKI, there is also a risk of tumor formation. Therefore, 
we investigated whether iPSC-derived RPCs have a ther-
apeutic effect on AKI.
In the present study, we examined whether iPSC-
derived RPCs can protect against AKI in a rate model of 
IR. We showed that the differentiation efficiency of iPSCs 
to RPCs increased when cultured with Renal Epithelial 
Cell Growth Medium after stimulation with a nephro-
genic cocktail of factors. The injection of iPSC-derived 
RPCs combined with hydrogel, which provides a 3-D 
structure to the cells, into the kidney of rats with IR could 
improve renal function and attenuate tubular injury by 
forming renal tubules in the recipient rat kidney directly, 
promoting cell proliferation, reducing apoptosis, and reg-
ulating the microenvironment in the injured kidney.
Results
Efficient differentiation of RPCs from mouse iPSCs
To investigate whether iPSC-derived RPCs can improve 
AKI, we first used a nephrogenic cocktail of factors (includ-
ing retinoic acid, activin A, and BMP7) to induce iPSCs 
differentiation into RPCs (Additional file 1: Figure S1). The 
iPS cell line used in this study is tagged with a ubiquitously 
expressed gfp gene. The real-time PCR analysis showed 
that the expression of the RPC markers PAX2, WT1, Six2 
and CD24 increased after RAB treatment (Fig.  1a), indi-
cating that RPCs were successfully induced. As shown 
by flow cytometry analysis, the PAX2, WT1 and CD24 
positive cells were 33.16, 19.56 and 27.82  % respectively 
(Fig.  1b). Additionally, the mature renal markers AQP1 
Fig. 1 Efficient differentiation of renal progenitor cells from mouse 
induced pluripotent stem cells (iPSCs). The renal differentiation of 
mouse iPSCs was initiated by the formation of embryoid bodies (EBs). 
After 2 days, retinoic acid, activin A, and BMP7 were added to the 
differentiation medium, and the cells were exposed to this supple‑
mented media for 5 days (RAB group). After incubation with growth 
factors for 5 days, the EBs in the RAB + REGM group were cultured in 
renal epithelial cell growth medium for another 5 days. a Real‑time 
PCR analysis of the expression of mesoderm (Bry) and renal lineage 
genes (Pax2, Osr1, WT1, Six2, CD24, Sal1, AQP1, E‑cad and PDGFR). 
b Flow cytometry analysis of the expression of mesoderm renal 
progenitor‑related genes. Black line, cells stained with isotype control; 
Red line, cells stained with indicated antibodies. *P < 0.05
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and E-cadherin were up-regulated upon RAB stimulation 
(Fig. 1a). To improve the differentiation efficiency of iPSCs 
into RPCs, the cells were cultured in renal epithelial cell 
growth medium for another 5 days (Additional file 1: Figure 
S1). As expected, the expression of the RPCs markers was 
further up-regulated compared with that of the RAB group, 
as shown by real-time PCR analysis after 5 days of differ-
entiation in RAB medium (Fig.  1a). Moreover, the PAX2, 
WT1, and CD24 single-positive cells increased to 52.56, 
27.8 and 36.24 % respectively (Fig. 1b), indicating that more 
RPCs were generated in the RAB + REGM group.
Therapeutic effect of iPSC‑derived RPCs in rats 
with IR‑induced AKI
Next, the rat IR model was generated by occlusion of the 
left renal artery followed by reperfusion and right kidney 
removal. iPSC-derived RPCs from the RAB  +  REGM 
group were injected directly into the renal parenchyma 
of the injured rats in combination with the hydrogel. 
The control group (IR-control) was injected with PBS 
combined with the hydrogel. The levels of BUN and Scr 
were detected at the indicated times. The plasma levels 
of BUN and Scr reached their peak levels at day 1 of renal 
IR in all groups and then decreased gradually (Fig.  2a, 
b). After RPC transplantation, the plasma levels of BUN 
and Scr were lower than those of the IR-control group 
(Fig. 2a, b). To test whether the RPC transplantation has 
beneficial effects on regeneration after IR, the rats were 
sacrificed on days 3, 7, 14, and 28, and the renal histology 
was examined. H&E staining showed that the proximal 
tubule in the renal cortex in the control group exhibited 
acute injury and necrosis 3  days after surgery (Fig.  3a): 
Fig. 2 Generation of rat renal ischemia–reperfusion model. The rat renal ischemia–reperfusion injury (IR) model was generated by occlusion of 
the left renal artery followed by reperfusion and right kidney removal. iPSC‑derived renal progenitor cells were injected into the renal parenchyma 
of the injured rats in combination with a hydrogel. The Scr (a) and BUN (b) levels in the plasma were detected at the indicated times. *P < 0.05 vs. 
IR‑Control
Fig. 3 Transplantation of iPSC‑derived renal progenitor cells improved renal tubular damage caused by ischemia–reperfusion. a Pathological 
changes in the kidney on the third day after surgery, as shown by H&E staining. Luminal debris, loss of brush borders and lumen expansion are 
observed in the injured groups (black arrow). b The transplantation of iPSC‑derived renal progenitor cells reduced the acute tubular necrosis scores. 
c The immunohistochemistry analysis indicated that the injected GFP‑positive cells formed a tubular structure (black arrow) in the recipient organ at 
the indicated times after transplantation. *P < 0.05 vs. IR‑Control. Scale bar 50 μm
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the brush border of some epithelial cells disappeared; 
the lumen expanded; some of the tubular epithelial cells 
detached from the basement membrane; the tubule was 
obstructed with cellular debris; and the interstitial tubule 
was infiltrated with inflammatory cells. The histological 
features of necrotic injury were still severe 7  days after 
ischemia and began to improve on days 14 and 28. The 
injury phenotype was decreased in the rat kidney as a 
result of RPC transplantation. The quantitative analysis 
of the renal tubular necrosis using the grading scores of 
Paller et  al. [22] is shown in Fig.  3b. These results sug-
gest that the transplantation of iPSC-derived RPCs could 
improve renal regeneration and function after AKI.
Mechanistic study of the improvement in the renal tubular 
damage caused by IR as a result of iPSC‑derived RPC 
transplantation
We further investigated the mechanism through which 
RPCs relieve acute renal injury caused by IR. Previ-
ous studies have reported that mouse kidney progenitor 
cells accelerate renal regeneration after ischemic injury 
by differentiation into epithelial cells and incorporating 
into the renal tubule [9, 23–25]. Thus, we first examined 
the localization of the transplanted iPSC-derived RPCs. 
Because the iPS cell line used in our study carries a ubiq-
uitously expressed gfp gene, it is convenient to trace the 
injected cells. Using immunohistochemistry, we showed 
that GFP-positive cells began to form a tubular structure 
in the recipient kidney 7  days after injection (Fig.  3c). 
Importantly, no tumor was detected even 3 months after 
transplantation. Next, the effects of the RPCs on the 
proliferation and apoptosis of cells in the injured kidney 
were examined by PCNA staining and TUNEL analy-
ses, respectively. The results showed that the number 
of PCNA-positive cells increased in the transplanted 
group compared with that found in the control group 
on days 7 after injection (Fig. 4a, b), indicating the pres-
ence of a greater number of proliferating renal tubular 
epithelial cells in the kidney after RPC transplantation. 
In contrast, the cell apoptosis on days 7 was reduced in 
the RPC-transplanted group, as shown by TUNEL analy-
sis (Fig. 4c, d). Furthermore, we detected the expression 
levels of the anti-inflammatory factors interleukin-10 
(IL-10), basic fibroblast growth factor (bFGF), and trans-
forming growth factor β1 (TGF-β1) and growth factors 
promoting renal tubular cell repair, namely epidermal 
growth factor (EGF), hepatocyte growth factor (HGF), 
and platelet-derived growth factor (PDGF). The real-time 
PCR analysis showed that the expression of these genes 
was upregulated to different extents after RPC transplan-
tation (Fig. 5). Altogether, these data indicate that iPSC-
derived RPC transplantation improves renal function 
after IR by directly incorporating into the renal tubule, 
promoting cell proliferation, reducing apoptosis, and 
upregulating the expression of pro-renal factors.
Discussion
AKI is an emerging worldwide public health problem 
with high mortality and morbidity rates and has thus 
attracted increasing attention. Although traditional ther-
apies show benefits in the treatment of AKI, the thera-
peutic approaches are still very limited. Recently, stem 
Fig. 4 Cell proliferation was increased and apoptosis was decreased in the transplanted renal parenchyma. a The proliferation of renal tubular cells 
was increased 7 days after cell transplantation, as determined by PCNA staining. b Quantitative analysis of PCNA‑positive cells in a. c Renal tubular 
cell apoptosis was decreased 7 days after cell transplantation, as determined by TUNEL assay. d Quantitative analysis of c. *P < 0.05 vs. IR‑Control. 
Scale bar 50 μm
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cell-based therapy appeared to be a potential strategy 
for the prevention of AKI [26]. In the present study, we 
provide the first demonstration that the transplantation 
of iPSC-derived RPCs improves renal regeneration and 
function in a rat model of IR-induced AKI, and the pro-
tective effect of the RPCs was mediated by their direct 
differentiation into renal lineage cells and incorpora-
tion into the renal tubule, which resulted in the promo-
tion of cell proliferation and the reduction of apoptosis 
in the damaged zone. Furthermore, the transplantation 
of iPSC-derived RPCs promoted the expression of anti-
inflammatory factors and pro-renal tubular repair 
factors, suggesting that RPCs can regulate the micro-
environment and facilitate cell survival in the injured 
kidney.
After ischemic injury, RPCs and mesenchymal stem 
cells (MSCs) resident in the kidney are activated and 
show some level of regenerative ability. Several studies 
have shown the therapeutic potential of isolated primary 
RPCs or MSCs in experimental AKI models. However, 
these cells are not available in large volumes. Recent 
advances demonstrated that iPSCs may be more read-
ily accessible for kidney regeneration [16]. Therefore, 
in our study, iPSCs were differentiated into renal line-
age cells to obtain a sufficient number of RPCs. To the 
traditional induction medium, we added renal specific 
growth medium for further induction. Using this modi-
fied protocol, the differentiation efficiency of iPSCs into 
RPCs and mature renal epithelial cells increased. Because 
kidney regeneration requires many functionally distinct 
cell types of the nephron, the transplantation of all renal 
cell types derived from iPSCs may offer the advantage of 
generating more than one cell type of the adult kidney.
In previous studies, stem cells for the treatment of 
AKI were mainly injected through the tail vein or the 
intrarenal artery [9, 16], and the transplanted stem cells 
in the circulation are mobilized to the injury site in the 
kidney mediated by chemokines/cytokines and receptor 
interaction and thereafter enhance renal regeneration. 
However, the homing efficiency cannot be determined. 
In our study, RPCs were injected directly into the renal 
parenchyma in combination with a hydrogel. A hydrogel 
consists of a network of polymer chains, and the func-
tion and structure of a hydrogel are similar to those of 
a natural extracellular matrix. Therefore, hydrogels are 
currently widely used as scaffolds in tissue engineering 
[27–30]. The hydrogel used in our work is composed of 
polypeptides and can be degraded into natural amino 
acids in vivo; thus, the hydrogel has no hazardous effect 
on the injured tissue. After being injected into the renal 
parenchyma with the RPCs, the liquid hydrogel will 
quickly transform into a solid structure, which provides 
a three-dimensional microenvironment for RPC adhe-
sion, migration, proliferation and differentiation. Our 
results showed that the exogenous cells formed a tubular 
structure in the injured kidney, indicating that the RPCs 
could migrate out of the hydrogel and participate in renal 
regeneration.
Fig. 5 Anti‑inflammatory factors and pro‑renal tubular repair factors increased after renal progenitor cell transplantation. Real‑time PCR analysis 
of the expression of anti‑inflammatory factors (IL‑10, FGF, and TGF‑β) and pro‑renal tubular repair factors (EGF, HGF, and PDGF) on D3, D7, D14, and 
D28. The anti‑inflammatory factors and pro‑renal tubular repair factors in the renal cortex of rats after cell transplantation are up‑regulated com‑
pared with the levels observed in the control group. *P < 0.05 vs. IR‑Control
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The therapeutic mechanisms of primary RPCs for AKI 
were recently investigated in several studies [9, 23, 31]. It 
has been reported that the transplanted RPCs can differ-
entiate into renal tubule cells and vessel endothelial cells 
with the expression of E-cadherin and CD34 [23] and 
therefore accelerate renal regeneration and prolong sur-
vival after AKI. Our result that iPSC-derived RPCs can 
differentiate into renal tubule cells and form renal tubules 
in the injured kidney further supports this hypothesis. 
Moreover, we showed that the transplantation of iPSC-
derived RPCs promoted cell proliferation and decreased 
apoptotic events. The cells also exhibited an anti-inflam-
matory effect by increasing the expression of anti-inflam-
matory factors, including TGF-β1. A recent study [32] 
reported that the presence of TGF-β1 in the homogen-
ate of acute IR-injured renal tissue markedly increases 
the CXCR4 surface expression of MSCs and promotes 
the migration of MSCs to SDF-1. Therefore, we hypothe-
sized that the transplantation of RPCs increased the level 
of TGF-β1 in the injured zone, which in turn regulated 
the CXCR4 expression of the RPCs, contributing to the 
migration of the RPCs out of the hydrogel to the injured 
sites. However, this proposed mechanism requires fur-
ther investigation.
Collectively, the present study demonstrated that the 
transplantation of iPSC-derived RPCs is able to protect 
against kidney injury in an experimental IR rat model. 
These cells function in both differentiation-dependent 
and -independent manners by directly forming renal 
tubules and exerting pro-proliferative, anti-apoptotic, 
and anti-inflammatory effects. Our data suggest that 
iPSC-derived RPCs are a potential cellular resource for 
stem cell-based therapy for IR-induced AKI.
Conclusions
This study reports a modified method for the differentia-
tion of iPSCs into RPCs and provides experimental evi-
dence that iPSC-derived RPCs combined with a hydrogel 
can improve renal function in AKI and reduce tubu-
lar injury in an animal IR model. We believe that iPSC-
derived RPCs hold great potential to be used as seed cells 
for personalized treatment in regenerative medicine.
Methods
IPSCs culture
Undifferentiated iPSCs were routinely cultured and 
expanded on mitotically inactivated MEFs (50,000 cells/
cm2) in six-well culture plates with mES medium: DMEM 
supplemented with 15 % FBS, l-glutamine, nonessential 
amino acids, β-mercaptoethanol (Gibco), and 1000 U/ml 
LIF (Millipore). The iPS cell line used in the present study 
was purchased from SiDanSai Biotechnology (Shanghai, 
China). The sequence of gfp gene, for tracing the iPSCs 
and iPSC-derived cells, was inserted into the chromo-
some of iPSCs. iPSCs transduced with this sequence 
showed robust expression of GFP.
Renal differentiation of murine iPSCs
iPSCs were differentiated through embryoid body (EB) 
formation in EB medium (DMEM supplemented with 
15  % FBS, l-glutamine, nonessential amino acids, and 
β-mercaptoethanol). On day 3 of differentiation, the EBs 
were transferred to gelatin-coated culture dishes at a den-
sity of 10 EBs per 1 ml of medium. The cells in the control 
group were maintained in EB medium for 5 days, and the 
medium was changed every 2 days. The cells in the induc-
tion group were exposed to a nephrogenic cocktail of fac-
tors, including 0.1 μM RA (Sigma), 10  ng/ml activin-A 
(PeproTech), and 50 ng/ml BMP7 (PeproTech), in the EB 
medium for 5 days. The induced cells were then cultured 
in the EB medium alone (RAB group) or in Renal Epi-
thelial Cell Growth Medium (RAB +  REGM group) for 
another 5 days and harvested for further analyses.
Quantitative reverse‑transcriptase polymerase chain 
reaction (RT‑PCR)
The total RNA from cells or tissues was extracted using 
the TRIzol reagent according to the protocol delineated 
by the manufacturer (Invitrogen-Life Technologies). One 
microgram of total RNA was reverse transcribed into 
cDNA with oligo-dT primers and reverse transcriptase 
(Invitrogen-Life Technologies). Real-time quantitative 
PCR was performed using SYBR Green (Toyobo Co, 
Japan). The primers used in the amplification reaction are 
shown in Table 1.
Flow cytometry
The differentiated cells were detached from the flask 
using accutase (Invitrogen-Life Technologies). The single 
cells were fixed with 4  % paraformaldehyde (Sigma) for 
15 min, permeabilized with 0.5 % Triton x-100 (Sigma), 
and blocked with 3  % BSA (Gibco) for 30  min at room 
temperature. The cells were then incubated with the fol-
lowing primary antibodies for 1 h: Pax2 (1:100; Abcam), 
Bry (1:100; Abcam), E-cadherin (1:100; Cell Signaling 
Technology), CD24 (1:200; BD Biosciences), and WT1 
(1:50; Santa Cruz Biotechnology Inc). After washing 
three times, the cells were incubated with the secondary 
antibody conjugated to Alexa Fluor 594 (1:200; Invitro-
gen-Life Technologies). The cells were washed to remove 
any unbound antibody and then analyzed using a flow 
cytometer (Millipore).
Preparation of hydrogel and cell mixture for injection
Hydrogels belong to a class of biological materials and 
produce a nanoscale environment similar that of the 
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native extracellular matrix [27–30]. A hydrogel consists 
of 1  % self-assembling peptides (w/v) and 99  % water 
(w/v). The detailed constituents and properties and the 
detailed preparation of the hydrogel used in this study are 
detailed by the manufacturer (Beaver Nano Technolo-
gies, China). Briefly, the hydrogel (1 %) was sonicated for 
30 min before use. The cells were suspended with 50 µl 
of 10 % sucrose solution, and 50 µl of the cell suspension 
was rapidly and carefully mixed with 50 µl of 1 % hydro-
gel. Then, 100 μl of PBS (Corning) was carefully added to 
the top of the cell and hydrogel mixture for instantaneous 
gelation. The 1 % hydrogel (50 µl) diluted with 150 μl of 
PBS was used as a control.
Rat renal IR model and injection of RPCs
The renal IR model was generated in 8-week-old male 
Sprague–Dawley as described previously [16]. Briefly, 
thirty rats (3–3.5  kg) were anesthetized with chlo-
ral hydrate (0.2  mg/g, Sigma), and this step was fol-
lowed by exposure of the abdomen. For induction of 
total ischemia in the kidney, the left renal artery was 
clamped with a small vascular clamp for 45 min. Reper-
fusion was initiated by removal of the clamp. The right 
kidney was removed simultaneously. Thirty-four rats 
survived the IR surgery and no rats died in the follow-
ing experiments. Then, the hydrogel (200  μl; denoted 
“IR-control” group) or the suspension of iPSC-derived 
RPCs (1 × 105 cells in 200 μl of 0.25 % hydrogel per rat; 
denoted “IR-transplantation” group) was respectively 
injected into the renal parenchyma of rats (seventeen 
rats per group). The rats were injected with the immu-
nosuppressant cyclosporine A (Sigma) at a dose of 
5 mg/kg per day. Six sham-operated animals underwent 
similar operative procedures but without clamping of 
the left renal artery and right kidney nephrectomy. At 
the indicated time, the blood was collected to measure 
the levels of blood urea nitrogen (BUN) and serum cre-
atinine (Scr). The rats were killed at the indicated days 
for the collection of kidney tissue samples. All care and 
handling of animals was performed with the approval 
of the Ethical Review Board of Shanghai Six People’s 
Hospital Affiliated to Shanghai Jiaotong University. The 
animals were raised in a specific pathogen-free (SPF) 
environment.
Histological analysis and tubular injury score
For the histological analysis, the kidney tissues were 
fixed with 4 % paraformaldehyde overnight and embed-
ded in paraffin. The paraffin sections  (4  μm) were 
stained with hematoxylin and eosin (H&E, Sigma). The 
quantitative analysis of the renal tubular injury used 
the grading scores proposed in a previous study [22]. 
The sections were evaluated by assessing 10 randomly 
selected high-power fields (40  ×  objective), and higher 
scores represented more severe damage: tubular epithe-
lial cell flattening (1 point), brush border loss (1 point), 
cell membrane bleb formation (1 or 2 points), interstitial 
edema (1 point), cytoplasmic vacuolization (1 point), cell 
necrosis (1 or 2 points), and tubular lumen obstruction (1 
or 2 points).
Table 1 Primers used for quantitative reverse-transcriptase polymerase chain reaction (RT-PCR)
Genes Forward primer (5′–3′) Reverse primer (5′–3′)
m‑PAX2 AAGCCCGGAGTGATTGGTG CAGGCGAACATAGTCGGGTT
m‑WT1 CAGTTCCCCAACCATTCCTT AAGCTGGGAGGTCATTTGGT
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Immunohistochemistry
Immunohistochemical staining was performed with 
mouse anti-GFP antibody (1:100; Cell Signaling Technol-
ogy) and mouse anti-proliferating cell nuclear antigen 
(PCNA, 1:200; Abcam). Briefly, paraffin sections of the 
kidneys were deparaffinized with xylene and rehydrated 
in an alcohol series and water. The kidney sections were 
subjected to antigen retrieval and blocked with a per-
oxidase-blocking reagent. The sections were incubated 
with the primary antibody overnight at 4 °C. After wash-
ing, the kidney sections were incubated with horseradish 
peroxidase-conjugated secondary antibody (ZSJQ-BIO, 
China) for 1  h at room temperature. The sections were 
visualized with 3,3′-diaminobenzidine (DAB, ZSGQ-
BIO) and counterstained with hematoxylin. The number 
of positive cells was evaluated by counting the stained 
cells per high-power field in at least 20 randomly selected 
fields. The apoptotic cells in the kidney were detected by 
terminal deoxynucleotidyl transferase (TdT)-mediated 
digoxigenin deoxyuridine nick-end labeling (TUNEL, 
Promega) staining according to the protocol delineated 
by the manufacturer. The TUNEL-negative controls were 
stained without TdT enzyme.
Statistical analysis
All of the experiments were performed at least three 
times. The data are shown as the mean ±  SEM. Differ-
ences were analyzed using one-way analysis of variance 
(ANOVA). Values of P  <  0.05 were considered statisti-
cally significant.
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